CPRX

CPRX EBITDA Margin

56.06%TTM

Period ending:

CPRX FY EBITDA Margin%
CPRX FY EBITDA Margin907.29%-7904.16%
2002-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

CPRX ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 24 observations from Dec 31, 2002 to Dec 31, 2025.

Catalyst Pharmaceuticals Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
54.566%
51.6615%
31.9916%
49.4662%
37.5331%
34.7644%
31.1595%
-7,051.4374%
0%
0%
0%
0%
0%
0%
0%
-817.7471%
0%
0%
0%
0%
0%
0%
0%
0%

Compare ebitda margin

All CPRX financial metrics · CPRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.